Chronic intermittent intravenous insulin therapy: A new frontier in diabetes therapy

Diabetes Technology and Therapeutics

Volumn 3, Issue 1, 2001, Pages 111-123

  Aoki, T T ^a   Grecu, E O ^a   Arcangeli, M A ^a   Benbarka, M M ^a   Prescott, P ^a   Jong Ho Ahn, ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AUTONOMIC NEUROPATHY; CIRCADIAN RHYTHM; CONFERENCE PAPER; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC NEPHROPATHY; GLUCOSE INTAKE; HYPERTENSION; HYPOGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN TREATMENT; ORTHOSTATIC HYPOTENSION; OUTPATIENT; PORTAL VEIN; PRIORITY JOURNAL;

BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIA; INJECTIONS, INTRAVENOUS; INSULIN;

EID: 0035036261     PISSN: 15209156     EISSN: None     Source Type: Journal    
DOI: 10.1089/152091501750220073     Document Type: Conference Paper

References (77)

1. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings
2. The B-cell in diabetes: From molecular genetics to clinical research
3. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects
4. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type 1 diabetic humans
5. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro
6. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man
7. Hepatic glucose production oscillates in synchrony with the islet secretary cycle in fasting rhesus monkeys
8. Portal and peripheral vein immunoreactive insulin concentrations before and after glucose infusion
9. Insulin concentrations in portal venous and peripheral venous blood in man following administration of glucose, galactose, xylitol and tolbutamide
10. Blood glucose and the liver
11. Regulation of glucokinase in liver
12. Fructose 2.6-bisphosphate 2 years after its discovery
13. Insulin production rate, hepatic insulin retention, and splanchnic carbohydrate metabolism after oral glucose ingestion in hyperinsulinemic type II (non-insulin dependent) diabetes mellitus
14. Insulin exerts metabolic and growth-promoting effects by a direct action on the liver in vivo: Clarification of the functional significance of the portal vascular link between the beta-cells of the pancreatic islets and the liver
15. Integrated physiology of carbohydrate metabolism
16. The control of glycogen metabolism in the liver
17. Peripheral effects of insulin dominate suppression of fasting hepatic glucose production
18. Effect of portal and peripheral venous insulin infusion on glucose production and utilization in depancreatized, conscious dogs
19. Modifications of glucose storage and oxidation in nonobese diabetics, measured by continuous indirect calorimetry
20. The theoretical bases of indirect calorimetry: A review
21. Evidence for restoration of hepatic glucose processing in type I diabetes mellitus
22. Restoration of glucose homeostasis in insulin-dependent diabetic subjects
23. 2 production after oral glucose administration in man
24. The glucose uptake inhuman adipose tissue in obesity
25. Effects of glucose infusion on adipose tissue lipogenesis in man
26. The effect of insulin on the respiratory quotient, oxygen consumption, sugar utilization and glycogen synthesis in the normal mammalian heart in hyper- and hypoglycemia
27. Effects of glucose and insulin on metabolism and function of perfused rat kidney
28. A study in man of cerebral blood flow and cerebral glucose, lactate and pyruvate metabolism before and after eating
29. Absorption and disposition of a glucose load in the conscious dog
30. Long-term intermittent intravenous insulin therapy and type 1 diabetes mellitus
31. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
32. Risk factors for progression of background retinopathy in longstanding IDDM
33. Blood pressure, proteinuria and their relationship with circulatory mortality: The WHO multinational study of vascular disease in diabetics
34. A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetes with diabetic nephropathy
35. Management of hypertension in the patient with diabetes mellitus
36. Diabetic control and the renin-angiotensin system, catecholamines and blood pressure
37. Peripheral blood flow and metabolic control in juvenile diabetes
38. Mechanisms of Hypertension in diabetes mellitus
39. Effect of chronic intermittent intravenous insulin therapy on anti_hypertensive medication requirements in IDDM subjects with hypertension and nephropathy
40. Role of cellular calcium metabolism in abnormal glucose metabolism and diabetic hypertension
41. Effects of insulin on vasoconstrictive responses to norepinephrine and angiotensin II in rabbit femoral artery and vein
42. Chronic intrarenal hyperinsulinemia does not cause hypertension
43. Hyperinsulinemia produces sympathetic neuronal activation and vasodilatation in normal humans
44. Insulin and the vasculature - Old actors, new roles
45. Diabetic nephropathy
46. Diabetic nephropathy
47. High glucose concentration causes a decrease in mesangium degradation
48. Effect of antihypertensive treatment on kidney function in diabetic nephropathy
49. Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus
50. Long term correction of hyperglycemia and progression of renal failure in insulin-dependent diabetes
51. Clinical and histological correlations of decline in renal function in diabetic patients with proteinuria
52. Effect of intensive insulin therapy on progression of overt diabetic nephropathy in patients with IDDM
53. Effects of pulsatile intravenous insulin therapy (PIVIT) on the progression of diabetic nephropathy
54. Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients
55. Hyperglycemia and diabetic kidney disease: The case for transforming growth factor β as a key mediator
56. The prevalence of autonomic neuropathy in insulin-dependent diabetes mellitus: A controlled study based on heart rate variability
57. The natural history of diabetic autonomic neuropathy
58. Factors in the development of diabetic neuropathy: Baseline analysis of neuropathy in the feasibility phase of Diabetes Control and Complications Trial
59. Twenty-four hour blood pressure and heart rate profiles of diabetic patients with abnormal cardiovascular reflexes
60. Circadian blood pressure variation in diabetic patients with autonomic neuropathy
61. Circadian blood pressure changes and left ventricular hypertrophy in hypertension
62. Dippers and nondippers
63. Effect of intensive insulin therapy on abnormal circadian blood pressure pattern in patients with type 1 diabetes mellitus
64. Influence of glucose metabolism on nictimeral blood pressure variability in hypertensives with an elevated waist hip ratio
65. Arterial wall compliance in diabetes
66. Circadian blood pressure variation in diabetic patients with autonomic neuropathy
67. Prevalence of diabetic autonomic neuropathy measured by simple bed-site tests
68. Diabetic autonomic neuropathy
69. Diabetic neuropathies
70. Noradrenergic responses in postural hypotension: Implications for therapy
71. Pathophysiology in diabetic autonomic neuropathy: Cardiovascular, hormonal, and metabolic studies
72. Diabetic neuropathy screening and management
73. Treatment of orthostatic hypotension with octreotide
74. Chronic intermittent intravenous insulin therapy corrects orthostatic hypotension of diabetes
75. The endocrinology of vasoactive peptides: Synthesis to function
76. Reversal of severe nonischemic dilated cardiomyopathy by intensive intravenous insulin therapy in a patient with NIDDM